These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36660550)

  • 1. Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study.
    Teekaput C; Teekaput K; Thiankhaw K
    Ther Clin Risk Manag; 2023; 19():35-42. PubMed ID: 36660550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of preseptal and pretarsal onabotulinum toxin an injection in patients with hemifacial spasm.
    Yılmaz ATC; Yılmaz M; Öztekin MF
    Int J Neurosci; 2021 Jun; 131(6):549-554. PubMed ID: 32233985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
    Kilduff CL; Casswell EJ; Salam T; Hersh D; Ortiz-Perez S; Ezra D
    JAMA Ophthalmol; 2016 Nov; 134(11):1247-1252. PubMed ID: 27606483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of a regional variant of botulinum toxin type A in the treatment of essential blepharospasm and hemifacial spasms: A retrospective study.
    Maneksha V; Chakrabarty S; Tanwar M; Pillai MR
    Indian J Ophthalmol; 2021 Oct; 69(10):2777-2781. PubMed ID: 34571634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
    Price J; Farish S; Taylor H; O'Day J
    Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Injection Botulinum Toxin in Blepharospasm.
    Amatya M; Limbu B; Sthapit PR; Gurung HB; Saiju R
    Nepal J Ophthalmol; 2021 Jan; 13(25):40-49. PubMed ID: 33981096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
    Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
    J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach.
    Rayess YA; Awaida CJ; Jabbour SF; Ballan AS; Sleilati FH; Abou Zeid SM; Nasr MW
    Rev Neurol (Paris); 2021; 177(1-2):107-114. PubMed ID: 32654779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm.
    Price J; O'Day J
    Aust N Z J Ophthalmol; 1994 Nov; 22(4):255-60. PubMed ID: 7727103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
    Park YC; Lim JK; Lee DK; Yi SD
    J Korean Med Sci; 1993 Oct; 8(5):334-40. PubMed ID: 8305141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm].
    Lasalvia CG; Pereira Lde S; da Cunha MC; Kitadai SP
    Arq Bras Oftalmol; 2006; 69(5):701-5. PubMed ID: 17187139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
    Li XH; Lin SC; Hu YF; Liu LY; Liu JB; Hong YC
    Eye Sci; 2012 Dec; 27(4):178-81. PubMed ID: 23225838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.